Bio-Bridge Science, Inc. has signed a definitive agreement to buy a 51% share of Xinheng Baide Biotechnology Co. Ltd., located in Inner Mongolia in China. The purchase price of the stake is 6 million RMB ($865,000). Xinheng Baide manufactures bovine serum, which is used in the production of vaccines and in scientific research. Bio-Bridge expects the deal to close at the end of May 2008. Xinheng Baide is in the same business as a new JV that Bio-Bridge announced three weeks ago.  More details...

Stock Symbol: (OTCBB: BGES)